30 Years of Evidence
Join the experts’ corner
Discover Accuray Exchange (AEx)!
Access our extensive on-demand webinar library and sign up for upcoming events.
Featured Content
Breast Cancer awareness
Lung-heart Toxicity in a Randomized Clinical Trial of Hypofractionated Image Guided Radiation Therapy for Breast Cancer
Breast Cancer awareness
Surface Guided Ring Gantry Radiotherapy in Deep Inspiration Breath Hold for Breast Cancer Patients
Breast Cancer awareness
Cosmetic Outcomes of a Phase 1 Dose Escalation Study of 5-Fraction Stereotactic Partial Breast Irradiation for Early Stage Breast Cancer
Featured Case Studies
Deep Inspiration Breath Hold Using VitalHold™ on the Radixact® System
A 45-year-old female patient was diagnosed with pT2N1M0 invasive ductal carcinoma of the left breast. The patient underwent breast conservation surgery with axillary dissection, followed by chemotherapy and radiation therapy. Radiation therapy was delivered by the Radixact® System, the latest generation of the TomoTherapy® Platform with surface guided radiotherapy (SGRT)
Las Vegas CyberKnife® Experience with CyberKnife VOLO™ Optimization: Increase in Patient Throughput & Daily Volumes
Las Vegas CyberKnife worked with Accuray to upgrade their CyberKnife G4 version 9.6 and MultiPlan® version 4.5 to decrease treatment planning times significantly with new planning hardware and optimized software in the first release of Accuray Precision 1.0 and treatment delivery version 11.0.
The CyberKnife® System Offers Alternative Treatment for Trigeminal Neuralgia
The Hôpital Notre-Dame du CHUM in Montreal, Canada, hosts a monthly clinic for patients with trigeminal neuralgia, a debilitating nerve disorder, that causes “electric” pain in the face. Eating, teeth brushing, shaving or simply a light gust of wind can trigger pain. In 2012, an 89-year-old male patient suffering from
Acute side effects after definitive stereotactic body radiation therapy (SBRT) for patients with clinically localized or locally advanced prostate cancer: a single institution prospective study
Jorgo K, Polgar C, Stelczer G, Major T, Gesztesi L, Agoston P | Radiol Oncol | 2021
Bleeding Risk Following Stereotactic Body Radiation Therapy for Localized Prostate Cancer in Men on Baseline Anticoagulant or Antiplatelet Therapy
Pepin A, Shah S, Pernia M, Lei S, Ayoob M, Danner M, Yung T, Collins BT, Suy S, Aghdam N, Collins SP | Front Oncol | 2021
Five-year outcomes of stereotactic body radiation therapy (SBRT) for prostate cancer: the largest experience in China
Zhao X, Ye Y, Yu H, Jiang L, Cheng C, Guo X, Ju X, Zhu X, Zhang H. | J Cancer Res Clin Oncol | 2021
Bothersome Hematospermia Following Stereotactic Body Radiation Therapy for Prostate Cancer
Sarthak Shah, Tamir Sholklapper , Michael Creswell, Abigail Pepin , Jonathan Cantalino, Ryan Andrew Hankins, Simeng Suy, Sean P Collins | Front Oncol | 2021
Short-Term Outcomes and Clinical Efficacy of Stereotactic Body Radiation Therapy (SBRT) for Oligometastases of Prostate Cancer in China
Chenyang Xu, Xianzhi Zhao, Xiaoping Ju, Yuxin Shen, Min Qu, Yusheng Ye, Xiaoyan Wang, Chunshan Yu, Xu Gao, Huojun Zhang | Front Oncol | 2022
High Dose “HDR-Like” Prostate SBRT: PSA 10-Year Results From a Mature, Multi-Institutional Clinical Trial
Fuller DB, Crabtree T, Kane BL, Medbery CA, Pfeffer R, Gray JR, Peddada A, Royce TJ, Chen RC | Front Oncol | 2022
Single fraction radiosurgery for the treatment of renal tumors
Staehler M, Bader M, Schlenker B, Casuscelli J, Karl A, Roosen A, Stief CG, Bex A, Wowra B, Muacevic A | J Urol | 2015
Phase I dose-escalation study of stereotactic body radiotherapy (SBRT) for poor surgical candidates with localized renal cell carcinoma
Ponsky L, Lo SS, Zhang Y, Schluchter M, Liu Y, Patel R, Abouassaly R, Welford S, Gulani V, Haaga JR, Machtay M, Ellis RJ | Radiother Oncol | 2015
